Cytokine regulation of cellular adhesion molecule expression in inflammation

Cytokine and Growth Factor Reviews

Volumn 10, Issue 1, 1999, Pages 27-39

  Meager, A ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Cellular adhesion molecule; Cytokine; Inflammation; Interleukin; Tumour necrosis factor

Indexed keywords

ANTIINFLAMMATORY AGENT; CD11B ANTIGEN; CD29 ANTIGEN; CD49 ANTIGEN; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE ANTAGONIST; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOTOXIN; PADGEM PROTEIN; SELECTIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE ADHERENCE; METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN EXPRESSION; SEPTIC SHOCK; SEPTICEMIA; SHORT SURVEY; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION MOLECULES; CYTOKINES; HUMANS; INFLAMMATION; INTEGRINS; SELECTINS;

ANIMALIA;

EID: 0033103110     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)00024-0     Document Type: Short Survey

References (113)

1. Zimmerman G.A., Prescott S.M., McIntyre T.M. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol. Today. 13:(3):1992;93-100.
2. Pardi R., Inverardi L., Bender J.R. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travellers. Immunology Today. 13:1992;224-230.
3. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:(2):1994;301-314.
4. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:(7):1994;2068-2101.
5. Imhof B.A., Dunon D. Leukocyte migration and adhesion. Adv. Immunol. 58:1995;345-416.
6. Luscinskas F.W., Gimbrone M.A. Jr. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu. Rev. Med. 47:1996;413-421.
7. Pigott R., Power C. The Adhesion Molecule Facts book. 1993;Academic Press, London and San Diego.
8. McEver R.P. Leukocyte interactions mediated by selectins. Thromb. Haemostasis. 66:1991;80.
9. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood. 88:(9):1996;3259-3287.
10. Gahmberg C.G., Tolvanen M., Kotovuori P. Leukocyte adhesion-structure and function of human leukocyte beta2-integrins and their cellular ligands. Eur. J. Biochem. 245:(2):1997;215-232.
11. Chothia C., Jones E.Y. The molecular structure of cell adhesion molecules. Annu. Rev. Biochem. 66:1997;823-862.
12. Berlin C., Berg E.L., Briskin M.J., et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 74:(1):1993;185-195.
13. Yang Y., Cardarelli P.M., Lehnert K., Rowland S., Krissansen G.W. LPAM-1 (integrin alpha 4 beta 7)-ligand binding: overlapping binding sites recognizing VCAM-1, MAdCAM-1 and CS-1 are blocked by fibrinogen, a fibronectin-like polymer and RGD-like cyclic peptides. Eur. J. Immunol. 28:(3):1998;995-1004.
14. Bazzoni G., Hemler M.E. Are changes in integrin affinity and conformation overemphasized? Trends Biochem. Sci. 23:(1):1998;30-34.
15. Nelson C., Rabb H., Arnaout M.A. Genetic cause of leukocyte adhesion molecule deficiency: Abnormal splicing and a missense mutation in a conserved region of CD18 impair cell surface expression of beta 2 integrins. J. Biol. Chem. 267:(5):1992;3351-3357.
16. Back A.L., Kwok W.W., Hickstein D.D. Identification of two molecular defects in a child with leukocyte adherence deficiency. J. Biol. Chem. 267:(8):1992;5482-5487.
17. Kehrli M.E. Jr, Ackermann M.R., Shuster D.E., et al. Bovine leukocyte adhesion deficiency: Beta 2 integrin deficiency in young Holstein cattle. Am. J. Pathol. 140:(6):1992;1489-1492.
18. Newman P.J. The biology of PECAM-1. J. Clin. Invest. 100:(11 Suppl):1997;S25-29.
19. Pober J.S., Bevilacqua M.P., Mendrick D.L., Lapierre L.A., Fiers W., Gimbrone M.A. Jr. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 136:(5):1986;1680-1687.
20. Bevilacqua M.P., Pober J.S., Wheeler M.E., Cotran R.S., Gimbrone M.A. Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Invest. 76:(5):1985;2003-2011.
21. Lawrence M.B., Springer T.A. Neutrophils roll on E-selectin. J. Immunol. 151:(11):1993;6338-6346.
22. Leeuwenberg J.F., von Asmuth E.J., Jeunhomme T.M., Buurman W.A. IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro. J. Immunol. 145:(7):1990;2110-2114.
23. Ghersa P., Hooft van Huijsduijnen R., Whelan J., DeLamarter J.F. Labile proteins play a dual role in the control of endothelial leukocyte adhesion molecule-1 (ELAM-1) gene regulation. J. Biol. Chem. 267:(27):1992;19226-19232.
24. Etter H., Althaus R., Eugster H.P., Santamaria Babi L.F., Weber L., Moser R. IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression. Cytokine. 10:(6):1998;395-403.
25. Mayadas T.N., Johnson R.C., Rayburn H., Hynes R.O., Wagner D.D. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 74:(3):1993;541-554.
26. Weller A., Isenmann S., Vestweber D. Cloning of the mouse endothelial selectins: Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J. Biol. Chem. 267:(21):1992;15176-15183.
27. Bischoff J., Brasel C. Regulation of P-selectin by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 210:(1):1995;174-180.
28. Ley K., Tedder T.F. Leukocyte interactions with vascular endothelium: New insights into selectin-mediated attachment and rolling. J. Immunol. 155:(2):1995;525-528.
29. Subramaniam M., Saffaripour S., Watson S.R., Mayadas T.N., Hynes R.O., Wagner D.D. Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. J. Exp. Med. 181:(6):1995;2277-2282.
30. Arbones M.L., Ord D.C., Ley K., et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity. 1:(4):1994;247-260.
31. Spertini O., Luscinskas F.W., Kansas G.S., et al. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J. Immunol. 147:(8):1991;2565-2573.
32. Luscinskas F.W., Kansas G.S., Ding H., et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J. Cell Biol. 125:(6):1994;1417-1427.
33. Tedder T.F., Steeber D.A., Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J. Exp. Med. 181:(6):1995;2259-2264.
34. Zakrzewicz A., Grafe M., Terbeek D., et al. L-selectin-dependent leukocyte adhesion to microvascular but not to macrovascular endothelial cells of the human coronary system. Blood. 89:(9):1997;3228-3235.
35. Kunkel E.J., Ley K. Distinct phenotype of E-selectin-deficient mice: E-selectin is required for slow leukocyte rolling in vivo. Circ. Res. 79:(6):1996;1196-1204.
36. Frenette P.S., Mayadas T.N., Rayburn H., Hynes R.O., Wagner D.D. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell. 84:(4):1996;563-574.
37. Newham P., Craig S.E., Clark K., Mould A.P., Humphries M.J. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes. J. Immunol. 160:(9):1998;4508-4517.
38. Sadhu C., Masinovsky B., Staunton D.E. Differential regulation of chemoattractant-stimulated beta 2, beta 3, and beta 7 integrin activity. J. Immunol. 160:(11):1998;5622-5628.
39. Vaddi K., Newton R.C. Regulation of monocyte integrin expression by beta-family chemokines. J. Immunol. 153:(10):1994;4721-4732.
40. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL 1 and interferon-gamma tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:(1):1986;245-254.
41. Rothlein R., Czajkowski M., O'Neill M.M., Marlin S.D., Mainolfi E., Merluzzi V.J. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J. Immunol. 141:(5):1988;1665-1669.
42. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiol. Rev. 70:(2):1990;427-451.
43. Wellicome S.M., Thornhill M.H., Pitzalis C., et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J. Immunol. 144:(7):1990;2558-2565.
44. Most J., Schwaeble W., Drach J., Sommerauer A., Dierich M.P. Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines. J. Immunol. 148:(6):1992;1635-1642.
45. Meager A. Bioimmunoassays for proinflammatory cytokines involving cytokine-induced cellular adhesion molecule expression in human glioblastoma cell lines. J. Immunol. Methods. 190:(2):1996;235-244.
46. Alexandroff A.B., Jackson A.M., Esuvaranathan K., Prescott S., James K. Autocrine regulation of ICAM-1 expression on bladder cancer cell lines: evidence for the role of IL-1 alpha. Immunol. Lett. 40:(2):1994;117-124.
47. Cartwright J.E., Whitley G.S., Johnstone A.P. The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes. Exp. Cell Res. 217:(2):1995;329-335.
48. Chadwick C.C., Shaw L.J., Winneker R.C. TNF-alpha and 9-cis-retinoic acid synergistically induce ICAM-1 expression: evidence for interaction of retinoid receptors with NF-kappa B. Exp. Cell Res. 239:(2):1998;423-429.
49. Kuppner M.C., Van Meir E., Hamou M.F., De Tribolet N. Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. Clin. Exp. Immunol. 81:1990;142-148.
50. Gamble J.R., Khew Goodall Y., Vadas M.A. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 150:(10):1993;4494-4503.
51. Voraberger G., Schafer R., Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region: Induction by cytokines and phorbol ester. J. Immunol. 147:(8):1991;2777-2786.
52. Wertheimer S.J., Myers C.L., Wallace R.W., Parks T.P. Intercellular adhesion molecule-1 gene expression in human endothelial cells: Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. J. Biol. Chem. 267:(17):1992;12030-12035.
53. Bouillon M., Audette M. Transduction of retinoic acid and gamma-interferon signal for intercellular adhesion molecule-1 expression on human tumor cell lines evidence for the late-acting involvement of protein kinase C inactivation. Cancer Res. 53:(4):1993;826-832.
54. Ishizuka T., Kawakami M., Hidaka T., et al. Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin. Exp. Immunol. 112:(3):1998;464-470.
55. Lakshminarayanan V., Beno D.W., Costa R.H., Roebuck K.A. Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factor-alpha in endothelial and epithelial cells. J. Biol. Chem. 272:(52):1997;32910-32918.
56. Palmer Crocker R.L., Pober J.S. IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J. Immunol. 154:(6):1995;2838-2845.
57. Ying S., Meng Q., Barata L.T., Robinson D.S., Durham S.R., Kay A.B. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Immunol. 158:(10):1997;5050-5057.
58. Sanz M.J., Marinova Mutafchieva L., Green P., Lobb R.R., Feldmann M., Nourshargh S. IL-4-induced eosinophil accumulation in rat skin is dependent on endogenous TNF-alpha and alpha 4 integrin/VCAM-1 adhesion pathways. J. Immunol. 160:(11):1998;5637-5645.
59. Yuan Q., Austen K.F., Friend D.S., Heidtman M., Boyce J.A. Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1). J. Exp. Med. 186:(2):1997;313-323.
60. Takeuchi M., Baichwal V.R. Induction of the gene encoding mucosal vascular addressin cell adhesion molecule 1 by tumor necrosis factor alpha is mediated by NF-kappa B proteins. Proc. Natl. Acad. Sci. USA. 92:(8):1995;3561-3565.
61. Romer L.H., McLean N.V., Yan H.C., Daise M., Sun J., DeLisser H.M. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J. Immunol. 154:(12):1995;6582-6592.
62. Lastres P., Almendro N., Bellon T., Lopez Guerrero J.A., Eritja R., Bernabeu C. Functional regulation of platelet/endothelial cell adhesion molecule-1 by TGF-beta 1 in promonocytic U-937 cells. J. Immunol. 153:(9):1994;4206-4218.
63. Chang C.H., Furue M., Tamaki K. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur. J. Immunol. 24:(11):1994;2889-2895.
64. Isberg R.R., Tran Van Nhieu G. Binding and internalization of microorganisms by integrin receptors. Trends Microbiol. 2:(1):1994;10-14.
65. Issekutz T.B. In vivo blood monocyte migration to acute inflammatory reactions, IL-1 alpha, TNF-alpha, IFN-gamma, and C5a utilizes LFA-1, Mac-1, and VLA-4: The relative importance of each integrin. J. Immunol. 154:(12):1995;6533-6540.
66. Lu H., Smith C.W., Perrard J., et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest. 99:(6):1997;1340-1350.
67. Meerschaert J., Furie M.B. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J. Immunol. 154:(8):1995;4099-4112.
68. Davis S.L., Hawkins E.P., Mason E.O. Jr, Smith C.W., Kaplan S.L. Host defenses against disseminated candidiasis are impaired in intercellular adhesion molecule 1-deficient mice. J. Infect. Dis. 174:(2):1996;435-439.
69. Kunkel E.J., Jung U., Bullard D.C., et al. Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J. Exp. Med. 183:(1):1996;57-65.
70. Sligh J.E. Jr, Ballantyne C.M., Rich S.S., et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 90:(18):1993;8529-8533.
71. Broide D.H., Humber D., Sriramarao P. Inhibition of eosinophil rolling and recruitment in P-selectin- and intracellular adhesion molecule-1-deficient mice. Blood. 91:(8):1998;2847-2856.
72. Mantovani A., Bussolino F., Introna M. Cytokine regulation of endothelial cell function from molecular level to the bedside. Immunol. Today. 18:(5):1997;231-240.
73. Read M.A., Whitley M.Z., Gupta S., et al. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272:(5):1997;2753-2761.
74. Mackay F., Loetscher H., Stueber D., Gehr G., Lesslauer W. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177:(5):1993;1277-1286.
75. Abe Y., Gatanaga M., Osuka Y., et al. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J. Immunol. 150:(11):1993;5070-5079.
76. Gerondakis S., Grumont R., Rourke I., Grossmann M. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:(3):1998;353-359.
77. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:(10):1995;899-909.
78. Iademarco M.F., McQuillan J.J., Dean D.C. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc. Natl. Acad. Sci. USA. 90:(9):1993;3943-3947.
79. Hou J., Baichwal V., Cao Z. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 91:(24):1994;11641-11645.
80. Liu K.D., Gaffen S.L., Goldsmith M.A. JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol. 10:(3):1998;271-278.
81. Jahnke A., Johnson J.P. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and IFN-gamma is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 alpha (p91) that can be activated by both IFN-gamma and IFN-alpha. FEBS Lett. 354:(2):1994;220-226.
82. Ahmad M., Theofanidis P., Medford R.M. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J. Biol. Chem. 273:(8):1998;4616-4621.
83. Palmer Crocker R.L., Hughes C.C., Pober J.S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J. Clin. Invest. 98:(3):1996;604-609.
84. Khachigian L.M., Collins T., Fries J.W. N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo. Am. J. Pathol. 151:(5):1997;1225-1229.
85. Spiecker M., Peng H.B., Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J. Biol. Chem. 272:(49):1997;30969-30974.
86. Masamune A., Hakomori S., Igarashi Y. N,N,N-trimethylsphingosine inhibits interleukin-1 beta-induced NF-kappa B activation and consequent E-selectin expression in human umbilical vein endothelial cells. FEBS Lett. 367:(2):1995;205-209.
87. Newman P.M., To S.S., Robinson B.G., Hyland V.J., Schrieber L. Effect of gold sodium thiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules. J. Clin. Invest. 94:(5):1994;1864-1871.
88. Wolle J., Ferguson E., Keshava C., et al. Inhibition of tumor necrosis factor induced human aortic endothelial cell adhesion molecule gene expression by an alkoxybenzo [b]thiophene-2-carboxamide. Biochem. Biophys. Res. Commun. 214:(1):1995;6-10.
89. Haridas V., Ni J., Meager A., et al. TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J. Immunol. 161:(1):1998;1-6.
90. Weber C., Negrescu E., Erl W., et al. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J. Immunol. 155:(1):1995;445-451.
91. Quezado Z.S., Banks S., Natanson C. New strategies for combatting sepsis: the magic bullets missed the mark but the search continues. Trends Biotechnol. 13:1995;56-63.
92. Grau G., Maennel D. TNF inhibition and sepsis-sounding a cautionary note. Conflicting results from anti-TNF trials in sepsis suggest that timely administration of TNF inhibitior drugs is crucial. Nature Med. 3:1997;1193-1195.
93. Opal S. Interleukin-1 receptor antagonist. Henderson B., Bodmer M. Therapeutic modulation of cytokines. 1996;197-219 CRC Press, Boca Raton.
94. Abraham E., Wunderink R., Silverman H., et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial. JAMA. 273:(12):1995;934-941. TNF-alpha MAb Sepsis Study Group.
95. Fisher C.J. Jr, Agosti J.M., Opal S.M., et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group [see comments]. N. Engl. J. Med. 334:(26):1996;1697-1702.
96. Abraham E., Glauser M.P., Butler T., et al. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock: A randomized controlled multicenter trial. JAMA. 277:(19):1997;1531-1538. Ro 45-2081 Study Group.
97. Travis J. Biotech gets a grip on cell adhesion [news]. Science. 260:(5110):1993;906-908.
98. Bullard D.C., Kunkel E.J., Kubo H., et al. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J. Exp. Med. 183:(5):1996;2329-2336.
99. Munoz F.M., Hawkins E.P., Bullard D.C., Beaudet A.L., Kaplan S.L. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. J. Clin. Invest. 100:(8):1997;2099-2106.
100. Mileski W.J., Winn R.K., Harlan J.M., Rice C.L. Transient inhibition of neutrophil adherence with the anti-CD18 monoclonal antibody 60.3 does not increase mortality rates in abdominal sepsis. Surgery. 109:(4):1991;497-501.
101. Xu H., Gonzalo J.A., St Pierre Y., et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180:(1):1994;95-109.
102. Friedman G., Jankowski S., Shahla M., et al. Administration of an antibody to E-selectin in patients with septic shock. Crit. Care Med. 24:(2):1996;229-233.
103. Lynn W.A., Cohen J. Adjunctive therapy for septic shock: a review of experimental approaches. Clin. Infect. Dis. 20:(1):1995;143-158.
104. Entman M.L., Youker K., Shoji T., Kukielka G., Shappell S.B., Taylor A.A., Smith C.W. Neutrophil induced oxidative injury of cardiac myocytes: a compartmented system requiring CD116/CD18-ICAM-1 adherence. J. Clin. Invest. 90:1992;1335-1345.
105. Hernandez L.A., Grisham M.B., Twohig B., Arfors K.E., Harlan J.M., Granger D.N. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol. 253:(3 Pt 2):1987;H699-703.
106. Kelly K.J., Williams W.W. Jr, Colvin R.B., et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 97:(4):1996;1056-1063.
107. Weyrich A.S., Ma X-L., Leger D.J., Albertine K.H., Lefer A.M. In vivo neutralisation of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:1993;2620-2629.
108. Winn R.K., Liggitt D., Vedder N.B., Paulson J.C., Harlan J.M. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J. Clin. Invest. 92:(4):1993;2042-2047.
109. Lowe J.B., Ward P.A. Therapeutic inhibition of carbohydrate-protein interactions in vivo. J. Clin. Invest. 100:(11 Suppl):1997;S47-51.
110. Kelly K.J., Williams W.W. Jr, Colvin R.B., Bonventre J.V. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. USA. 91:(2):1994;812-816.
111. Rabb H., Mendiola C.C., Saba S.R., et al. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem. Biophys. Res. Commun. 211:(1):1995;67-73.
112. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3 K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:(6616):1997;540-544.
113. Wallach D., Kovalenko A.V., Varfolomeev E.E., Boldin M.P. Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict. Curr. Opin. Immunol. 10:(3):1998;279-288.